课题基金 / 基金详情

Study on Humoral Factor in Renal Allotransplantation with Special Regard to MLC Activation Factor

Study on Humoral Factor in Renal Allotransplantation with Special Regard to MLC Activation Factor
同种异体肾移植中体液因子特别是MLC激活因子的研究
批准号:
62480341
负责人:
HATA Makoto
金额:
$3.26万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1987
资助国家:
日本
项目状态:
已结题
起止时间:
1987 至 1989

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
促使我们开展这一研究项目的是,我们注意到在我所接受同种异体肾移植的患者中,有4例患者术前血清中存在MLC激活因子(S),并可能由于这些激活因子(S)的存在而经历了特殊的术后过程。根据对其临床病程的观察,认为这种MLC激活因子(S)可能诱发难治性排斥反应,这种作用可被DST所抑制。本研究旨在阐明MLC激活因子(S)的免疫机制。第一年:(1)经血清学试验证实激活因子(S)对MLC具有特异性。(2)将自回归模型作为急性排斥反应的诊断工具之一,对免疫网络进行分析。(3)观察门静脉给药对狗肾移植移植物存活时间的影响。第二年:(1)大鼠异基因输注后,测定腹腔巨噬细胞的前列腺素E和丙二醛的生成。静脉或门静脉注射DST的不同途径对移植物存活无明显影响,但其作用机制因输血途径不同而不同。(2)对急性排斥反应的免疫学诊断,实质上是观察移植肾这一靶器官发生的免疫现象。为此,有必要在安全和重复的基础上从肾脏获取试验标本。为了满足这一要求,采用杂种犬模型对细针吸取细胞学(FNAC)的可行性进行了研究。最后一年:尽一切努力做出最终报告,以便在医学大会上展示我们的结果并发表在医学期刊上。
英文摘要
What prompted us to conduct this research project was that we noted 4 particular cases among patients having undergone renal allotransplantion in our institution, who had MLC activation factor (s) in their serum prior to the operation and experienced peculiar post-operative courses presumably because of presence of these activation factor (s). Based on the observation of their clinical courses, it was considered that this MLC activation factor (s) might induce refractory rejection and this action could be suppressed by DST. The purpose of this study is to clarify the immune mechanism of the MLC activation factor (s).The 1st year : (1) specificity of the activation factor (s) was proved by serological test for MLC. (2) Immunological net work was analyzed by using self regression model as one of diagnostic tools for acute rejection. (3) The effect of DST via portal vein was examined on prolongation of graft survival in renal allotransplantation using mongrel dogs.The second year : (1) PGE & TBX productivity by intraperitoneal macrophages was examined after alogeneic transfusion in rats. The different routes of DST, intravenously or portal venously, did not make any difference in immunosuppressive effect in terms of graft survival but their mechanism seemed to be different according to the routes of transfusion. (2) In order to make immunological diagnosis of acute rejection, substantial way is to investigate the immunological phenomena taking place in the target organ, namely the transplanted kidney. For this purpose, it is neccessary to obtain the test specimens from the kidney on the safe and repeated basis. To meet this requirement, feasibility of fine needle aspiration cytology (FNAC) was examined by using mongrel dog model.The final year : All efforts were paid to make final report so that our results were presented at medical convention and also published in medical journals.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
畠 亮,馬場 志郎,田崎 寛: "両側性副腎腫瘍に対する正常組織温存手術" 内分泌外科. 6. 339-342 (1989)
Ryo Hatake、Shiro Baba、Hiroshi Tasaki:“双侧肾上腺肿瘤的正常组织保留手术”内分泌外科。 6. 339-342 (1989)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
出口修宏: 今日の移植.
Nobuhiro Deguchi:今天的移植手术。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Hata,S.Baba,M.Tachibana,N.Deguchi,S.Jitsukawa,H.Tazaki: "Reduction of the blood boss in adrenalectomy by using CUSA and through the subostal transperitoneal approach" Endocrine Surgery. 6. 99-102 (1989)
M.Hata、S.Baba、M.Tachibana、N.Deguchi、S.Jitsukawa、H.Tazaki:“通过使用 CUSA 和通过腹膜下入路减少肾上腺切除术中的血流”内分泌外科。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
畠亮、馬場志郎、早川邦弘、朝倉博孝、中村薫、出口修宏、田崎寛: "ラット同種間輸血と腹腔内マクロファ-ジのprostaglnndin,Thromboxane産生能ー末梢系輸血と門脈系輸血との対比においてー" 腎移植・血管外科. 1. 105-110 (1989)
Ryo Hatake、Shiro Baba、Kunihiro Hayakawa、Hirotaka Asakura、Kaoru Nakamura、Nobuhiro Deguchi、Hiroshi Tasaki:“大鼠同种异体输血与腹腔巨噬细胞前列腺素和血栓素产生能力 - 外周血输血与门静脉输血的比较”在“肾病”中移植和血管外科。1. 105-110 (1989)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 14 条
    海外基金